|
| Exchange Disseminated Time 18/10/2016 14:29:36 | Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on October 27, 2016, inter alia, to consider Unaudited Financial Results of the Company for the quarter ended September 30, 2016 (Q2).
Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for the Designated Persons of the Company from October 20, 2016 to October 29, 2016 (both days inclusive). |
|
|